1
|
Sawabata N, Asamura H, Goya T, et al:
Japanese Lung Cancer Registry Study: first prospective enrollment
of a large number of surgical and nonsurgical cases in 2002. J
Thorac Oncol. 5:1369–1375. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Pujol JL, Barlesi F and Daures JP: Should
chemotherapy combinations for advanced non-small cell lung cancer
be platinum-based? A meta-analysis of phase III randomized trials.
Lung Cancer. 51:335–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE
and Gottesman MM: P-glycoprotein: from genomics to mechanism.
Oncogene. 22:7468–7485. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Huang Y and Sadee W: Membrane transporters
and channels in chemoresistance and sensitivity of tumor cells.
Cancer Lett. 239:168–182. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lee JT Jr, Steelman LS and McCubrey JA:
Phosphatidylinositol 3′-kinase activation leads to multidrug
resistance protein-1 expression and subsequent chemoresistance in
advanced prostate cancer cells. Cancer Res. 64:8397–8404. 2004.
|
6
|
Giannakakou P, Sackett DL, Kang YK, et al:
Paclitaxel-resistant human ovarian cancer cells have mutant
beta-tubulins that exhibit impaired paclitaxel-driven
polymerization. J Biol Chem. 272:17118–17125. 1997. View Article : Google Scholar
|
7
|
Monzó M, Rosell R, Sánchez JJ, et al:
Paclitaxel resistance in non-small-cell lung cancer associated with
beta-tubulin gene mutations. J Clin Oncol. 17:1786–1793.
1999.PubMed/NCBI
|
8
|
Hua XH, Genini D, Gussio R, et al:
Biochemical genetic analysis of indanocine resistance in human
leukemia. Cancer Res. 61:7248–7254. 2001.PubMed/NCBI
|
9
|
Gonzalez-Garay ML, Chang L, Blade K,
Menick DR and Cabral F: A beta-tubulin leucine cluster involved in
microtubule assembly and paclitaxel resistance. J Biol Chem.
274:23875–23882. 1999. View Article : Google Scholar : PubMed/NCBI
|
10
|
McGrogan BT, Gilmartin B, Carney DN and
McCann A: Taxanes, microtubules and chemoresistant breast cancer.
Biochim Biophys Acta. 1785:96–132. 2008.PubMed/NCBI
|
11
|
Orr GA, Verdier-Pinard P, McDaid H and
Horwitz SB: Mechanisms of Taxol resistance related to microtubules.
Oncogene. 22:7280–7295. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Berrieman HK, Lind MJ and Cawkwell L: Do
beta-tubulin mutations have a role in resistance to chemotherapy?
Lancet Oncol. 5:158–164. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kavallaris M, Tait AS, Walsh BJ, et al:
Multiple microtubule alterations are associated with Vinca alkaloid
resistance in human leukemia cells. Cancer Res. 61:5803–5809.
2001.PubMed/NCBI
|
14
|
Hari M, Loganzo F, Annable T, et al:
Paclitaxel-resistant cells have a mutation in the
paclitaxel-binding region of beta-tubulin (Asp26Glu) and less
stable microtubules. Mol Cancer Ther. 5:270–278. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yang H and Cabral F: Heightened
sensitivity to paclitaxel in Class IVa beta-tubulin-transfected
cells is lost as expression increases. J Biol Chem.
282:27058–27066. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Aoki D, Oda Y, Hattori S, et al:
Overexpression of class III beta-tubulin predicts good response to
taxane-based chemotherapy in ovarian clear cell adenocarcinoma.
Clin Cancer Res. 15:1473–1480. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
18
|
Sumizawa T, Chen ZS, Chuman Y, et al:
Reversal of multidrug resistance-associated protein-mediated drug
resistance by the pyridine analog PAK-104P. Mol Pharmacol.
51:399–405. 1997.PubMed/NCBI
|
19
|
Shi Z, Tiwari AK, Shukla S, et al:
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine
kinase inhibitor AG1478. Biochem Pharmacol. 77:781–793. 2009.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Minotti AM, Barlow SB and Cabral F:
Resistance to antimitotic drugs in Chinese hamster ovary cells
correlates with changes in the level of polymerized tubulin. J Biol
Chem. 266:3987–3994. 1991.PubMed/NCBI
|
21
|
Westermann S and Weber K:
Post-translational modifications regulate microtubule function. Nat
Rev Mol Cell Biol. 4:938–947. 2003. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Sasse R and Gull K: Tubulin
post-translational modifications and the construction of
microtubular organelles in Trypanosoma brucei. J Cell Sci.
90:577–589. 1988.PubMed/NCBI
|
23
|
Belhoussine R, Morjani H, Sharonov S,
Ploton D and Manfait M: Characterization of intracellular pH
gradients in human multidrug-resistant tumor cells by means of
scanning microspectrofluorometry and dual-emission-ratio probes.
Int J Cancer. 81:81–89. 1999. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jiang LW, Maher VM, McCormick JJ and
Schindler M: Alkalinization of the lysosomes is correlated with ras
transformation of murine and human fibroblasts. J Biol Chem.
265:4775–4777. 1990.PubMed/NCBI
|
25
|
Altan N, Chen Y, Schindler M and Simon SM:
Defective acidification in human breast tumor cells and
implications for chemotherapy. J Exp Med. 187:1583–1598. 1998.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Gong Y, Duvvuri M and Krise JP: Separate
roles for the Golgi apparatus and lysosomes in the sequestration of
drugs in the multidrug-resistant human leukemic cell line HL-60. J
Biol Chem. 278:50234–50239. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kokkonen N, Rivinoja A, Kauppila A, Suokas
M, Kellokumpu I and Kellokumpu S: Defective acidification of
intracellular organelles results in aberrant secretion of cathepsin
D in cancer cells. J Biol Chem. 279:39982–39988. 2004. View Article : Google Scholar : PubMed/NCBI
|
28
|
Alvarez M, Paull K, Monks A, et al:
Generation of a drug resistance profile by quantitation of
mdr-1/P-glycoprotein in the cell lines of the National Cancer
Institute Anticancer Drug Screen. J Clin Invest. 95:2205–2214.
1995. View Article : Google Scholar : PubMed/NCBI
|